PharmaOPS.BXL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PharmaOPS.BXL
Largest movements
- Financial fixed assets +€1.2m
up €1.2m (+8580.5%), from €14,000 to €1.2m
- Intangible fixed assets +€979,870
up €979,870 (+225.4%), from €434,797 to €1.4m
- Stocks and contracts +€273,882
up €273,882 (+209.8%), from €130,517 to €404,399
- Receivables within one year +€170,171
up €170,171 (+134.2%), from €126,843 to €297,014
of which Trade receivables: +€168,435
- Cash -€101,628
down €101,628 (-45.3%), from €224,539 to €122,911
mainly Investment in fixed assets (net) (-€2.4m) and Stocks and contracts (-€273,882)
- Debts after one year +€1.6m
up €1.6m (+204.7%), from €774,893 to €2.4m
of which Financial debts: +€1.4m
- Trade debts +€430,709
up €430,709 (+638.5%), from €67,455 to €498,164
- Accrued charges and deferred income +€215,505
up €215,505 (+1957.3%), from €11,010 to €226,515
- Other debts +€213,696
new in 2024: €213,696
- Current portion of long-term debt +€131,150
up €131,150 (+188.4%), from €69,624 to €200,773
- Gross operating margin +€531,182
up €531,182 (+815.3%), from €65,148 to €596,330
- Staff costs +€287,321
up €287,321 (+629.9%), from €45,612 to €332,933
- Depreciation +€128,497
up €128,497 (+734.9%), from €17,485 to €145,982
- Financial charges +€81,280
up €81,280 (+1033.0%), from €7,868 to €89,148
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €987,675 | €3,559,500 | +€2.6m | +260.4% |
| Fixed assets | 21/28 | €505,141 | €2,728,844 | +€2.2m | +440.2% |
| Intangible fixed assets | 21 | €434,797 | €1,414,668 | +€979,870 | +225.4% |
| Tangible fixed assets | 22/27 | €56,344 | €98,903 | +€42,560 | +75.5% |
| Land and buildings | 22 | - | €17,985 | +€17,985 | |
| Plant, machinery and equipment | 23 | €46,397 | €71,431 | +€25,034 | +54.0% |
| Furniture and vehicles | 24 | €9,947 | €9,487 | -€460 | -4.6% |
| Financial fixed assets | 28 | €14,000 | €1,215,273 | +€1.2m | +8580.5% |
| Current assets | 29/58 | €482,534 | €830,656 | +€348,122 | +72.1% |
| Stocks and contracts in progress | 3 | €130,517 | €404,399 | +€273,882 | +209.8% |
| Stocks | 30/36 | €130,517 | €404,399 | +€273,882 | +209.8% |
| Amounts receivable within one year | 40/41 | €126,843 | €297,014 | +€170,171 | +134.2% |
| Trade receivables | 40 | €126,426 | €294,861 | +€168,435 | +133.2% |
| Other amounts receivable | 41 | €417 | €2,153 | +€1,736 | +416.3% |
| Cash at bank and in hand | 54/58 | €224,539 | €122,911 | -€101,628 | -45.3% |
| Deferred charges and accrued income | 490/1 | €635 | €6,332 | +€5,696 | +896.5% |
| Total equity and liabilities | 10/49 | €987,675 | €3,559,500 | +€2.6m | +260.4% |
| Equity | 10/15 | €1,000 | €6,268 | +€5,268 | +526.8% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | - | €5,268 | +€5,268 | |
| Amounts payable | 17/49 | €986,675 | €3,553,232 | +€2.6m | +260.1% |
| Amounts payable after more than one year | 17 | €774,893 | €2,361,484 | +€1.6m | +204.7% |
| Financial debts | 170/4 | €574,893 | €2,011,484 | +€1.4m | +249.9% |
| Other amounts payable | 178/9 | €200,000 | €350,000 | +€150,000 | +75.0% |
| Amounts payable within one year | 42/48 | €200,772 | €965,233 | +€764,461 | +380.8% |
| Current portion of amounts payable after more than one year | 42 | €69,624 | €200,773 | +€131,150 | +188.4% |
| Trade debts | 44 | €67,455 | €498,164 | +€430,709 | +638.5% |
| Suppliers | 440/4 | €67,455 | €498,164 | +€430,709 | +638.5% |
| Advances received on contracts in progress | 46 | €49,593 | €821 | -€48,772 | -98.3% |
| Taxes, remuneration and social security | 45 | €14,100 | €51,778 | +€37,678 | +267.2% |
| Taxes | 450/3 | €4,811 | €9,186 | +€4,374 | +90.9% |
| Remuneration and social security | 454/9 | €9,289 | €42,592 | +€33,304 | +358.5% |
| Other amounts payable | 47/48 | - | €213,696 | +€213,696 | |
| Accrued charges and deferred income | 492/3 | €11,010 | €226,515 | +€215,505 | +1957.3% |
| Remuneration, social security and pensions | 62 | €45,612 | €332,933 | +€287,321 | +629.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €17,485 | €145,982 | +€128,497 | +734.9% |
| Other operating charges | 640/8 | €2,126 | €775 | -€1,352 | -63.6% |
| Non-recurring operating charges | 66A | - | €27,050 | +€27,050 | |
| Gross operating margin | 9900 | €65,148 | €596,330 | +€531,182 | +815.3% |
| Operating profit (loss) | 9901 | -€76 | €89,590 | +€89,666 | |
| Financial income | 75/76B | €876 | €5,376 | +€4,500 | +513.5% |
| Recurring financial income | 75 | €876 | €5,376 | +€4,500 | +513.5% |
| Financial charges | 65/66B | €7,868 | €89,148 | +€81,280 | +1033.0% |
| Recurring financial charges | 65 | €7,868 | €89,148 | +€81,280 | +1033.0% |
| Profit (loss) for the period before taxes | 9903 | -€7,068 | €5,818 | +€12,885 | |
| Income taxes | 67/77 | - | €550 | +€550 | |
| Profit (loss) for the period | 9904 | -€7,068 | €5,268 | +€12,336 | |
| Profit (loss) for the period to be appropriated | 9905 | -€7,068 | €5,268 | +€12,336 |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.